Publications:

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.

Acs Omega

Mahalapbutr, Panupong P; Leechaisit, Ronnakorn R; Thongnum, Anusit A; Todsaporn, Duangjai D; Prachayasittikul, Veda V; Rungrotmongkol, Thanyada T; Prachayasittikul, Supaluk S; Ruchirawat, Somsak S; Prachayasittikul, Virapong V; Pingaew, Ratchanok R

Publication Date: 2022-05-31

Variant appearance in text: EGFR: L718A

PubMed Link: 35664590

Variant Present in the following documents:

• Main text
• ao2c01188.pdf

View BVdb publication page

Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.

Oncotarget

Xu, Jing J; Wang, Jinghui J; Zhang, Shucai S

Publication Date: 2017-10-27

Variant appearance in text: EGFR: L718A

PubMed Link: 29163853

Variant Present in the following documents:

• Main text
• oncotarget-08-90557.pdf

View BVdb publication page

Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationships.

Bmc Genomics

Goyal, Sukriti S; Jamal, Salma S; Shanker, Asheesh A; Grover, Abhinav A

Publication Date: 2015

Variant appearance in text: EGFR: L718A

PubMed Link: 26041145

Variant Present in the following documents:

• Main text
• 1471-2164-16-S5-S8.pdf

View BVdb publication page